Luis Rivera

2.0k total citations
22 papers, 410 citations indexed

About

Luis Rivera is a scholar working on Epidemiology, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Luis Rivera has authored 22 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 10 papers in Infectious Diseases and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Luis Rivera's work include Viral Infections and Immunology Research (6 papers), Respiratory viral infections research (6 papers) and Viral gastroenteritis research and epidemiology (5 papers). Luis Rivera is often cited by papers focused on Viral Infections and Immunology Research (6 papers), Respiratory viral infections research (6 papers) and Viral gastroenteritis research and epidemiology (5 papers). Luis Rivera collaborates with scholars based in United States, Panama and Chile. Luis Rivera's co-authors include Xavier Sáez‐Llorens, Suely Tuboi, Delia Yu, Vianney Tricou, Derek Wallace, Astrid Borkowski, Sue Ann Costa Clemens, Roberto Tapia‐Conyer, José Jimeno and José Ignacio Santos and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Luis Rivera

18 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luis Rivera United States	11	230	219	144	76	32	22	410
Yelin Roca Bolivia	13	318 1.4×	291 1.3×	143 1.0×	39 0.5×	51 1.6×	20	519
Inge Lefevre Switzerland	10	156 0.7×	158 0.7×	100 0.7×	43 0.6×	13 0.4×	22	274
Chee‐Fu Yung Singapore	6	182 0.8×	187 0.9×	100 0.7×	16 0.2×	23 0.7×	8	337
Jason Martin United States	11	89 0.4×	217 1.0×	178 1.2×	39 0.5×	10 0.3×	20	348
Cuitláhuac Ruíz-Matus Mexico	11	151 0.7×	146 0.7×	79 0.5×	16 0.2×	15 0.5×	24	298
Sergey Diorditsa Philippines	9	94 0.4×	126 0.6×	162 1.1×	110 1.4×	22 0.7×	11	290
Phengta Vongphrachanh United States	13	98 0.4×	204 0.9×	220 1.5×	46 0.6×	7 0.2×	26	463
Shuyun Xie China	12	145 0.6×	179 0.8×	225 1.6×	55 0.7×	13 0.4×	43	456
Varja Grabovac Philippines	10	99 0.4×	229 1.0×	87 0.6×	28 0.4×	102 3.2×	23	316
Adriana S. Tan Singapore	8	160 0.7×	208 0.9×	197 1.4×	25 0.3×	28 0.9×	8	404

Countries citing papers authored by Luis Rivera

Since Specialization

Citations

This map shows the geographic impact of Luis Rivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Rivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Rivera more than expected).

Fields of papers citing papers by Luis Rivera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Rivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Rivera. The network helps show where Luis Rivera may publish in the future.

Co-authorship network of co-authors of Luis Rivera

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Rivera. A scholar is included among the top collaborators of Luis Rivera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Rivera. Luis Rivera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schully, Kevin L., Melissa K. Gregory, Joost Brandsma, et al.. (2024). Retrospective Analysis of Blood Biomarkers of Neurological Injury in Human Cases of Viral Infection and Bacterial Sepsis. The Journal of Infectious Diseases. 231(3). 805–815.

Moreno, Brechla, Luis Rivera, Jean‐Paul Carrera, et al.. (2023). Detection of parechovirus A in respiratory, gastrointestinal, and neurological clinical samples of pediatric patients from Panama (2014–2015). Virology Journal. 20(1). 302–302.

Callegaro, Andrea, Jyoti Soni, Luis Rivera, et al.. (2021). Association Between Hemagglutination Inhibition Antibody Titers and Protection Against Reverse-Transcription Polymerase Chain Reaction–Confirmed Influenza Illness in Children 6–35 Months of Age: Statistical Evaluation of a Correlate of Protection. Open Forum Infectious Diseases. 9(2). ofab477–ofab477. 5 indexed citations

Bandyopadhyay, Ananda S, Chris Gast, Luis Rivera, et al.. (2020). Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial. The Lancet Infectious Diseases. 21(4). 559–568. 17 indexed citations

Tricou, Vianney, Xavier Sáez‐Llorens, Delia Yu, et al.. (2020). Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial. The Lancet. 395(10234). 1434–1443. 66 indexed citations

Barrera, Roberto, Gilberto Félix, Verónica Acevedo, et al.. (2019). Impacts of Hurricanes Irma and Maria on Aedes aegypti Populations, Aquatic Habitats, and Mosquito Infections with Dengue, Chikungunya, and Zika Viruses in Puerto Rico. American Journal of Tropical Medicine and Hygiene. 100(6). 1413–1420. 29 indexed citations

Sáez‐Llorens, Xavier, Vianney Tricou, Delia Yu, et al.. (2017). Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2–17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study. The Lancet Infectious Diseases. 18(2). 162–170. 58 indexed citations

Sáez‐Llorens, Xavier, Vianney Tricou, Delia Yu, et al.. (2017). Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study. The Lancet Infectious Diseases. 17(6). 615–625. 66 indexed citations

Rivera, Luis, Rasmus S. Pedersen, Lars Vibe Andreasen, et al.. (2017). Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial. The Lancet Infectious Diseases. 17(7). 745–753. 9 indexed citations

10.

Rivera, Luis, Xavier Sáez‐Llorens, Margaret Ip, et al.. (2015). Incidence and serotype distribution of invasive group B streptococcal disease in young infants: a multi-country observational study. BMC Pediatrics. 15(1). 143–143. 25 indexed citations

11.

Knuf, Markus, Geert Leroux‐Roels, H. C. Rümke, et al.. (2014). Immunogenicity and Tolerability of an MF59-adjuvanted, Egg-derived, A/H1N1 Pandemic Influenza Vaccine in Children 6–35 Months of Age. The Pediatric Infectious Disease Journal. 33(12). e320–e329. 10 indexed citations

12.

Knuf, Markus, Geert Leroux‐Roels, H. C. Rümke, et al.. (2014). Safety and immunogenicity of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age. Vaccine. 33(1). 174–181. 17 indexed citations

13.

Rivera, Luis, et al.. (2012). Phase III, randomized controlled trial to evaluate lot consistency of a trivalent subunit egg-based influenza vaccine in adults. Vaccine. 30(35). 5285–5292. 3 indexed citations

14.

Sefair, Jorge A., et al.. (2008). Car pooling optimization: A case study in Strasbourg (France). 89–94. 7 indexed citations

15.

Rivera, Luis, et al.. (2005). GRASP EN LA RESOLUCIÓN DEL PROBLEMA DE CLUSTERING. 2(2). 16–25.

16.

Jameel, Shahid, et al.. (2000). Hepatitis E virus in Cuba. Journal of Clinical Virology. 16(1). 71–75. 12 indexed citations

17.

Silveira, Themis Reverbel da, Luis Rivera, Oscar Fay, et al.. (1999). Hepatitis B seroprevalence in Latin America. Revista Panamericana de Salud Pública. 6(6). 378–83. 69 indexed citations

18.

Jameel, Shahid, et al.. (1995). REPORTE CORTO/SHORT REPORT - THE HEPATITIS C VIRUS INFECTION IN CUBA: ANTIBODY PATTERN AND GENOTYPES. TSpace (University of Toronto). 1 indexed citations

19.

Rivera, Luis, et al.. (1995). Antibody pattern to hepatitis C virus antigens in patients with acute and chronic liver diseases. Serodiagnosis and Immunotherapy in Infectious Disease. 7(1). 23–26. 1 indexed citations

20.

Sánchez, Giselle, et al.. (1994). Evaluación de un sistema para la detección de anticuerpos contra un antígeno sintético del core del virus de hepatitis C y su prevalencia en donantes de sangre. Biotecnología aplicada. 11(2). 165–170. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact